Compounds > 12-o-retinoylphorbol-13-acetate

12-o-retinoylphorbol-13-acetate and vanoxerine

12-o-retinoylphorbol-13-acetate has been researched along with vanoxerine* in 1 studies

Other Studies

1 other study(ies) available for 12-o-retinoylphorbol-13-acetate and vanoxerine

Article	Year
A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots. Chemical communications (Cambridge, England), 2012, Jun-04, Volume: 48, Issue:44 Here we present the development and validation of a flow cytometry-based dopamine transporter (DAT) binding assay that uses antagonist-conjugated quantum dots (QDs). We anticipate that our QD-based assay is of immediate value to the high throughput screening of novel DAT modulators. Topics: Binding, Competitive; Biotin; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation; HEK293 Cells; High-Throughput Screening Assays; Humans; Phorbol Esters; Piperazines; Polyethylene Glycols; Quantum Dots; Spectrometry, Fluorescence	2012

Article

Year

A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots.

Chemical communications (Cambridge, England), 2012, Jun-04, Volume: 48, Issue:44

Here we present the development and validation of a flow cytometry-based dopamine transporter (DAT) binding assay that uses antagonist-conjugated quantum dots (QDs). We anticipate that our QD-based assay is of immediate value to the high throughput screening of novel DAT modulators.

Topics: Binding, Competitive; Biotin; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation; HEK293 Cells; High-Throughput Screening Assays; Humans; Phorbol Esters; Piperazines; Polyethylene Glycols; Quantum Dots; Spectrometry, Fluorescence

2012